开发和初步临床可行性为患有喘的儿童提供基于Delphi的有氧运动处方
Ying Zhang1,2, Ze Kong1, Kaixuan Yang2
1Baoding Hospital of Beijing Children's Hospital, Capital Medical University, Baoding, China.
Frontiers in pediatrics
|December 25, 2025
概括
德尔菲开发的一种有氧运动处方对患有喘的儿童来说是安全的和可行的,显示了运动能力和肺功能的潜在改善. 需要进一步的研究来证实小儿喘管理的有效性.
科学领域:
- 儿科肺病学 儿科肺病学
- 运动生理学 运动生理学
- 非药理干预措施 非药理干预
背景情况:
- 儿童喘管理通常依赖于药理疗法.
- 需要基于证据的非药物干预措施,如有氧运动,以改善儿科喘的结果.
- 开发一个临床适用的运动处方需要专家的共识和试点测试.
研究的目的:
- 开发一种临床上适用的有氧运动处方,用于患有喘的儿童,使用两轮的德尔菲共识过程.
- 在前后试点研究中,初步评估此处方的可行性和安全性.
- 为了探索运动能力,肺功能和喘控制的初步变化,以响应运动处方.
主要方法:
- 通过与家长,医疗专业人员和体育康复专家进行半结构化采访,开发了最初的有氧运动处方.
- 该处方通过两轮的德尔菲咨询与儿童肺病学,护理和运动康复领域的17名专家进行了细化.
- 一项为期12周的试点研究涉及15名患有喘的儿童 (6-14岁),评估了可行性,安全性和临床结果,包括6分钟步行距离 (6MWD),螺旋计和儿童喘控制测试 (C-ACT).
主要成果:
- 德尔菲进程取得了高专家共识 (≥75%的同意,权威系数Cr=0.86).
- 试点研究表明100%的招聘率和良好的炼坚持 (2.7次/周).
- 在6MWD (P<0.001),FEV1%预测 (P<0.001) 和C-ACT得分 (P<0.001) 中观察到显著改善,轻度,非破坏性不良事件的发病率低 (13.3%).
结论:
- 德尔菲开发的有氧运动处方在患有喘的儿童中短期使用是可行的,也是安全的.
- 初步发现表明,对运动能力,肺功能和喘控制有潜在的益处.
- 需要对更大的样本大小和受控设计进行进一步的研究,以确认疗效和隔离干预效应.
相关概念视频
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
COPD: Management Using Bronchodilators and Corticosteroids
698
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
698
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K


